الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
11 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Amany Nasr Ahmed Mohammed Elemary 2023
12 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Prof. Ashraf Zeidan Abdalla Ahmed 2023
13 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Amany Mohammed Abdel Moatamed 2023
14 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Prof. Ashraf Zeidan Abdalla Ahmed 2023
15 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Salah Mabrouk Khallaf Abd Rabou 2023
16 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Dr. Marwa Tammam Ameen Hammam 2023
17 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Dr. Maged Abdelfatah Amine Hassan 2021
18 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Doaa Mohamed Fouad Mahmoud 2021
19 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Dr. Hanaan Ahmed Mohammed Ahmed 2021
20 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents Dr. Hanaan Ahmed Mohammed Ahmed 2021